Professional Title & Qualifications:
Associate Chief Physician, M.D., Ph.D.
Specialization:
Hospital & Department：
Shanghai General Hospital, Affiliated with Shanghai Jiao Tong University School of Medicine – Department of Orthopedic Oncology
Dr. Dongqing Zuo - Orthopedic Oncologist
Personal Biography
Dr. Dongqing Zuo is an Associate Chief Physician and Medical Doctor (M.D.) within the Department of Orthopedic Oncology at Shanghai General Hospital. He served as a visiting scholar at the Mayo Clinic, sponsored by the China Scholarship Council, and is a certified mentor for bone tumor ablation training by the National Health Commission (NHC).
Dr. Zuo specializes in the comprehensive surgical and medical treatment of difficult and complex bone and soft tissue tumors, with a particular focus on minimally invasive diagnosis and treatment. He has developed three new minimally invasive techniques and holds five related patents. He has led several major research projects, including the National Natural Science Foundation Youth Fund, the Shanghai Municipal Health Commission Clinical Research Project, and the Shanghai Shenkang Hospital Development Center Clinical Research Project. He has also served as the Principal Investigator (PI) for four clinical studies and as a Key Sub-Investigator for numerous other bone tumor clinical trials. Dr. Zuo has published over 10 SCI papers, including two with an impact factor greater than 10.
Book an online consultation with Dr. Dongqing Zuo
Areas of Expertise
-
Minimally invasive treatment for benign bone tumors (e.g., bone cysts, osteoid osteoma, osteoblastoma, enchondroma), serving as an NHC minimally invasive ablation training mentor.
-
Minimally invasive surgical treatment for spinal metastatic bone tumors, including percutaneous minimally invasive ablation, MISS (Minimally Invasive Spine Surgery) decompression, and UBE (Unilateral Biportal Endoscopy) combined with radiofrequency for spinal cord compression.
-
Minimally invasive treatment for pelvic and hip metastatic tumors, including the percutaneous screw and ablation "tripod" technique, cryoablation, and bone cement screw hip preservation.
-
Limb salvage treatment for complex soft tissue sarcomas, including various neoadjuvant therapies, management of positive surgical margins, and navigation-guided precision surgical resection.
-
Joint replacement and limb salvage surgery for tumors of the shoulder, hip, and knee, including segmental resection with conventional prosthesis reconstruction, biological composite reconstruction, and 3D printed prosthesis reconstruction.
-
Palliative radiofrequency ablation, cryoablation, and Iodine-125 radioactive seed implantation (brachytherapy) for recurrent and metastatic bone and soft tissue tumors.
-
Exploratory treatment and clinical trials for tenosynovial giant cell tumor, various soft tissue sarcomas, and lung metastases from bone and soft tissue sarcomas.
Clinical Highlights
-
Over 1,200 patients treated
-
100% treatment satisfaction rate
-
100% patient satisfaction with service attitude
Education
-
Ph.D., Orthopedics: Tongji University
-
Master's, Orthopedics: Tongji University
-
Bachelor's, Clinical Medicine: Nanjing Medical University
Work & Advanced Studies
-
Visiting Scholar: Department of Orthopedics, Mayo Clinic (October 2015 - February 2017), mentored by Dr. Yaszemski.
Social Appointments
-
Member, Digital Orthopedics Group, Bone Tumor and Bone Metastasis Committee, Chinese Anti-Cancer Association (CACA).
-
Member, International Exchange Promotion Working Committee, China Medical Education Association.
-
Member, Bone Tumor Group, Geriatric Orthopedics Branch, Chinese Geriatric Medical Society.
-
Member, Spine Tumor Group, Shanghai Rehabilitation Medical Association.
-
Member, Melanoma Committee, Shanghai Anti-Cancer Association.
Awards and Honors
-
Third Prize, Shanghai Medical Science and Technology Award (2021).
Research Achievements
-
Published dozens of clinical and basic research articles.
-
Hosted multiple projects, including the National Natural Science Foundation, Shanghai Municipal Health Commission clinical research, and CSCO (Chinese Society of Clinical Oncology) special projects.
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.